Ziopharm Oncology reported $-22639000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Amgen AMGN:US $ 2333M 204M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
AstraZeneca AZN:LN 1.4B 366M
Baxter International BAX:US $ 476M 50M
Biogen BIIB:US $ 858.6M 171.5M
Bristol Myers Squibb BMY:US $ 2985M 18M
Corcept Therapeutics CORT:US $ 31.94M 12.3M
Curis CRIS:US $ -10650000 1.85M
Eleven Biotherapeutics EBIO:US -25399000 29.82M
Gilead Sciences GILD:US $ 2246M 655M
GlaxoSmithKline GSK:LN 2.67B 712M
Immunogen IMGN:US $ -27369000 1.55M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
IONIS PHARMACEUT IONS:US $ -72969000 19M
Johnson & Johnson JNJ:US $ 7033M 2723M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Merk MRK:US $ 2269M 1993M
Novartis NOVN:VX 3.4B 415M
Pfizer PFE:US $ 6662M 905M
Ptc Therapeutics PTCT:US $ -98493000 345K
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48700000 2.4M
Tg Therapeutics TGTX:US $ -77492000 11.71M
Verastem VSTM:US $ -15944000 1.84M
YTE INCY:US $ 155.31M 40.5M
Ziopharm Oncology ZIOP:US $ -22639000 1.08M